| 摘要 |
PURPOSE: A pharmaceutical composition containing 5-hydroxytryptophan is provided to suppress phophorylation of ERK and LPS-induced iNOS and COX-2 gene expression and to ensure anti-inflammation effect. CONSTITUTION: A pharmaceutical composition for treating and preventing inflammation contains 5-hydroxytryptophan as an active ingredient and pharmaceutically acceptable carrier or excipient. The pharmaceutical composition is used in the form of powder, granule, tablet, capsule, suspension, emulsion, syrup, aerosol, suppository, or sterilized injection. A health food contains 5-hydroxytryptophan.
|
